{"transactions":[{"id":2874018,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":142934,"kind":"person","name":"Chapman Marcus","position":1,"cik":"0001770404","reported_name":"Chapman Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-08T23:55:02.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest as to 25% of the shares on February 4, 2022. The remainder of the shares will vest in 12 equal quarterly installments thereafter."}],"balance_after":24000,"derivative":{"exercise_price":26.34,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000899243-21-005254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924321005254/doc4.xml","form_type":"4"}},{"id":2874017,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":142934,"kind":"person","name":"Chapman Marcus","position":1,"cik":"0001770404","reported_name":"Chapman Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-02-08T23:55:02.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest and settle as to 25% of the restricted stock units on March 15, 2022. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest and settle as to 25% of the restricted stock units on March 15, 2022. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter."}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-21-005254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924321005254/doc4.xml","form_type":"4"}},{"id":3169936,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":142934,"kind":"person","name":"Chapman Marcus","position":1,"cik":"0001770404","reported_name":"Chapman Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2020-04-24T20:10:05.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":18596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on April 22, 2021."}],"balance_after":18596,"derivative":{"exercise_price":3.74,"expiration_date":"2030-04-21","underlying":"Common Stock","underlying_shares":18596},"source":{"system":"sec-edgar","filing":"0000899243-20-011277","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924320011277/doc4.xml","form_type":"4"}},{"id":3296220,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":142934,"kind":"person","name":"Chapman Marcus","position":1,"cik":"0001770404","reported_name":"Chapman Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2020-01-31T21:07:49.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares on January 29, 2021. The remainder of the shares will vest in 12 equal quarterly installments thereafter."}],"balance_after":125000,"derivative":{"exercise_price":3.3,"expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-20-002422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924320002422/doc4.xml","form_type":"4"}},{"id":3359658,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":142934,"kind":"person","name":"Chapman Marcus","position":1,"cik":"0001770404","reported_name":"Chapman Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-11-25T21:32:32.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested in full on November 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested in full on November 1, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-19-028069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924319028069/doc4.xml","form_type":"4"}},{"id":3359657,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":142934,"kind":"person","name":"Chapman Marcus","position":1,"cik":"0001770404","reported_name":"Chapman Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-11-25T21:32:32.000Z","date":"2019-11-22","kind":"sale","acquired":false,"shares":3400,"price":3.9108,"value":13296.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, dated June 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $3.93. The reporting person undertakes to provide Seres Therapeutics, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8600,"source":{"system":"sec-edgar","filing":"0000899243-19-028069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924319028069/doc4.xml","form_type":"4"}},{"id":3359656,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":142934,"kind":"person","name":"Chapman Marcus","position":1,"cik":"0001770404","reported_name":"Chapman Marcus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-11-25T21:32:32.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000899243-19-028069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924319028069/doc4.xml","form_type":"4"}}]}